Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

FDA grants 510k clearance to muscle and joint rehabilitation medical device

The Food and Drug Administration today granted 510(k) clearance to a muscle and joint rehabilitation medical device developed by OHSU Scientist Dr. Paul Cordo, Ph.D., and AMES Technology, Inc.

1 Jun 2013

Cytomegalovirus might accelerate the development of glioblastoma

A virus that infects most Americans but that usually remains dormant in the body might speed the progression of an aggressive form of brain cancer when particular genes are shut off in tumor cells, new research shows.

1 Jun 2013

Study suggests bright light therapy may improve sleep and brain function post mild TBI

A new study suggests that bright light therapy may improve sleep, cognition, emotion and brain function following mild traumatic brain injury (TBI).

1 Jun 2013

Alim Louis Benabid receives 2013 Robert A. Pritzker Prize for Leadership in Parkinson's Research

The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced that Alim Louis Benabid , MD, PhD, is the recipient of the 2013 Robert A. Pritzker Prize for Leadership in Parkinson's Research.

1 Jun 2013

International researchers find how brain cancer cells survive and drive tumor growth

An international team of researchers - led by principal investigator Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine - has found that a singular gene mutation helps brain cancer cells to not just survive, but grow tumors rapidly by altering the splicing of genes that control cellular metabolism.

1 Jun 2013

Synageva BioPharma presents data on cholesteryl ester storage disease at NLA annual meeting

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, announced three poster presentations at the National Lipid Association annual meeting held in Las Vegas, Nevada, May 30- June 2, 2013, as well as a Synageva-sponsored satellite symposium held on Friday, May 31, 2013.

1 Jun 2013

Glioblastoma patients treated with bevacizumab have deterioration in neurocognitive function

Many glioblastoma patients treated with bevacizumab (Avastin-) have significant deterioration in neurocognitive function, symptoms and quality of life. Not only that, the changes often predict treatment outcomes, according to new research from The University of Texas MD Anderson Cancer Center.

1 Jun 2013

Study points to synergistic relationship between lead exposure and schizophrenia gene

Mice engineered with a human gene for schizophrenia and exposed to lead during early life exhibited behaviors and structural changes in their brains consistent with schizophrenia.

1 Jun 2013

Experts to kick off Big Ten Cancer Research Consortium in Chicago

In athletics, the Big Ten universities compete against each other, but now many will join together against a common foe: cancer.

1 Jun 2013

Health care workers urge state officials to halt pending Medi-Cal payment cuts

Citing devastating impacts on California's most vulnerable patients, local hospital leaders joined with physicians and health care workers in Alameda County today to urge state officials to halt pending Medi-Cal payment cuts.

1 Jun 2013

GLYX-13 drug induces antidepressant results without street drug side effects

GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the street drug side effects, reported a study funded by the National Institute of Mental Health (NIMH) that was published last month in Neuropsychopharmacology.

31 May 2013

Omeros announces positive results from OMS824 Phase 1 clinical program

Omeros Corporation today announced positive results from its Phase 1 clinical program evaluating OMS824, the lead compound from its phosphodiesterase 10 (PDE10) program.

31 May 2013

Vanda Pharmaceuticals announces submission of tasimelteon NDA to FDA

Vanda Pharmaceuticals Inc. today announced the submission of a New Drug Application to the U.S. Food and Drug Administration for tasimelteon, a circadian regulator.

31 May 2013

Mayo Clinic experts provide some insight about radiation dose from CT imaging

Many misconceptions exist about the risks associated with radiation doses and CT scans. Experts at Mayo Clinic want patients to have the right information about radiation dose, including when to have procedures with radiation, such as a CT scan, versus when to have magnetic resonance imaging or other non-radiation tests.

31 May 2013

Measuring blood flow in the brain may predict stroke or hemorrhage in children on ECMO: Study

Measuring blood flow in the brain may be an easy, noninvasive way to predict stroke or hemorrhage in children receiving cardiac or respiratory support through a machine called ECMO, according to a new study by researchers at Nationwide Children's Hospital.

31 May 2013

Three easy steps for cancer survivorship

Incorporating just three easy steps into a daily routine can increase a cancer patient's chance at survival, according to a physician who specializes in cancer survivorship.

31 May 2013

Extremely low doses of THC protect the brain from long-term cognitive damage

Though marijuana is a well-known recreational drug, extensive scientific research has been conducted on the therapeutic properties of marijuana in the last decade. Medical cannabis is often used by sufferers of chronic ailments, including cancer and post-traumatic stress disorder, to combat pain, insomnia, lack of appetite, and other symptoms.

31 May 2013

Brain News and Research

Further Reading

FDA grants 510k clearance to muscle and joint rehabilitation medical device

Cytomegalovirus might accelerate the development of glioblastoma

Study suggests bright light therapy may improve sleep and brain function post mild TBI

Alim Louis Benabid receives 2013 Robert A. Pritzker Prize for Leadership in Parkinson's Research

International researchers find how brain cancer cells survive and drive tumor growth

Synageva BioPharma presents data on cholesteryl ester storage disease at NLA annual meeting

Glioblastoma patients treated with bevacizumab have deterioration in neurocognitive function

Study points to synergistic relationship between lead exposure and schizophrenia gene

Experts to kick off Big Ten Cancer Research Consortium in Chicago

Health care workers urge state officials to halt pending Medi-Cal payment cuts

GLYX-13 drug induces antidepressant results without street drug side effects

Omeros announces positive results from OMS824 Phase 1 clinical program

Vanda Pharmaceuticals announces submission of tasimelteon NDA to FDA

Mayo Clinic experts provide some insight about radiation dose from CT imaging

Measuring blood flow in the brain may predict stroke or hemorrhage in children on ECMO: Study

Three easy steps for cancer survivorship

Extremely low doses of THC protect the brain from long-term cognitive damage

Research gives hope: Patients' immune system could fight glioblastoma multiforme

Oncothyreon, Array BioPharma to develop and commercialize ARRY-380 for breast cancer patients

Isaiah J. Fidler earns 2013 American Cancer Society Medal of Honor for Basic Research

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News